Arbutus Biopharma Corp (NASDAQ: ABUS) Recovers 44.35% From 52-Week Low, Is ABUS Still A High-Risk, High-Reward Play?
Arbutus Biopharma Corp (NASDAQ:ABUS) currently has a daily average trading volume of 875.31K but it saw 1315959 shares traded in last market. With a market cap of 629.11M USD, the company’s current market price of $3.32 came rising about 4.08 while comparing to the previous closing price of $3.19. In past 52 weeks, the stock […]
Arbutus Biopharma Corp (NASDAQ: ABUS) – Time For Strategy Change?
Arbutus Biopharma Corp (NASDAQ:ABUS) currently has a daily average trading volume of 789.50K but it saw 1387507 shares traded in last market. With a market cap of 651.86M USD, the company’s current market price of $3.44 came falling about -0.29 while comparing to the previous closing price of $3.45. In past 52 weeks, the stock […]
More To Go Or Is It Over? – Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (NASDAQ:ABUS) does about 807.87K shares in volume on a normal day but saw 403774 shares change hands in the recent trading day. The company now has a market cap of 623.42M USD. Its current market price is $3.29, marking a decrease of -0.30% compared to the previous close of $3.30. The 52 […]
With 189.44M Outstanding Shares, Can Arbutus Biopharma Corp (NASDAQ: ABUS) Deliver Big Short-Term Gains?
Arbutus Biopharma Corp (NASDAQ:ABUS) currently has a daily average trading volume of 838.39K but it saw 1123976 shares traded in last market. With a market cap of 680.27M USD, the company’s current market price of $3.59 came rising about 6.85 while comparing to the previous closing price of $3.36. In past 52 weeks, the stock […]